Alcon AG
SIX:ALC
Operating Margin
Alcon AG
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| CH |
|
Alcon AG
SIX:ALC
|
36B CHF |
14%
|
|
| JP |
|
Hoya Corp
TSE:7741
|
6.6T JPY |
29%
|
|
| DK |
|
Coloplast A/S
CSE:COLO B
|
139.3B DKK |
27%
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
15B USD |
16%
|
|
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
5.9B CHF |
15%
|
|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.9B GBP |
15%
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
44.9B CNY |
43%
|
|
| US |
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
5B USD |
12%
|
|
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.1B USD |
3%
|
|
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
5B USD |
29%
|
|
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
6.6T KRW |
-149%
|
Alcon AG
Glance View
Alcon AG, headquartered in Geneva, Switzerland, emerges as a global leader in eye care, having spun off from Novartis in 2019 to operate independently. The company traces its roots back to a small pharmacy established in Fort Worth, Texas, in 1945, gradually expanding under the strategic vision of its founders. Today, Alcon stands at the intersection of innovation and necessity, catering to a world increasingly aware of eye health. The firm specializes in two main sectors: Surgical and Vision Care. In the Surgical division, Alcon offers advanced technologies and devices for ophthalmic surgery, encompassing cataract, retinal, and refractive procedures. Through these innovations, Alcon not only enhances patient outcomes but also streamlines operations for eye care professionals, carving out a significant market share in surgical solutions. Meanwhile, the Vision Care segment thrives by addressing the burgeoning demand for contact lenses and ocular health products. Alcon’s portfolio features daily disposable and reusable lenses, supported by innovative technologies that prioritize comfort and clarity of vision. Additionally, the company provides comprehensive eye care products, including lens care solutions, which enhance user satisfaction and ensure sustained demand. Alcon’s revenue model hinges on its ability to deliver cutting-edge products that meet the evolving needs of consumers and professionals alike. Through strategic investments in research and development and a strong distribution network, Alcon perpetually reinforces its market presence, securing its position as a formidable player in the eye care industry.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Alcon AG's most recent financial statements, the company has Operating Margin of 14.1%.
You don't have any saved screeners yet